CTIS.eu › Cities › France › STRASBOURG, Alsace
STRASBOURG, Alsace
France
16 total trials
12 recruiting
2025-520979-13-00
5
2025-12-18
Patients with HR+ HER2- early breast cancer at intermediate risk of re
2023-505486-92-00
4
2024-02-09
Small bowel adenocarcinoma
2025-522108-26-00
4
2026-02-19
métastatique colorectal cancer
2025-522395-92-00
5
2025-12-15
metastatic oeso-gastric adenocarcinoma
2023-509963-25-00
4
2025-01-17
Fluoropyrimidine (FP)-naive patients with gastrointestinal (GI) cancer
2023-507482-26-00
5
2024-10-04
Castrate-resistant prostate cancer with oligometastases on functional
2023-508100-38-00
5
2024-06-24
Advanced Biliary Cancer (ABC)
2023-505214-23-00
5
2024-06-07
colon carcinoma
2024-512999-35-00
4
2023-06-23
Patients with HER 2 negative locally advanced, recurrent or metastatic
2023-510567-35-00
4
2020-06-10
Advanced / metastatic cancers
2024-514637-37-00
5
2020-02-11
Patients with bone sarcomas other than chordoma, who have no residual
2023-506027-29-00
5
2014-10-01
Children, adolescents and adults with newly diagnosed diffuse intrinsi
2024-518127-30-00
4
2021-11-26
MSI/dMMR tumors or EBV+ gastric cancer
2023-506782-56-00
5
2020-03-10
RET-Mutant Medullary Thyroid Cancer
2024-514829-36-00
5
2019-12-02
High-risk biochemically-relapsed prostate adenocarcinoma following rad
2024-513982-38-00
5
2021-03-17
Metastatic or unresectable advanced rare sarcomas
Showing 1–16 of 16 trials